Latest Interviews
Showing 1–7 of 7 transcripts.
Clear all filters- Milken Institute23 min
Conversation with CMS Administrator Mehmet Oz & HHS Chief Counselor Chris Klomp | Global Conference
Mehmet Oz, Chris Klomp, Esther Krofah
Under the strategic mandate "Making America Healthy Again," CMS Administrator Dr. Mehmet Oz and HHS leadership are overhauling the U.S. healthcare system by shifting from fee-for-service to value-based models that target upstream chronic disease prevention and address the nation's 27% unfilled prescription rate. The administration is enforcing strict integrity measures to eliminate $100 billion in annual fraud while simultaneously deploying AI to modernize legacy infrastructure and accelerate FDA drug approvals from 15 years to under five. These initiatives aim to align U.S. drug pricing with global "Most Favored Nation" standards and restore public trust in federal health agencies to counter competitive gaps with international rivals like China.
- Milken Institute21 min
US Department of Health & Human Services Deputy Secretary Jim O'Neill | Future of Health Summit 2025
The "Make America Healthy Again" agenda reorients the HHS from reactive sick care to preventive health by restoring the CDC's 1946 mission, recruiting AI and scientific specialists, and prioritizing radical transparency to rebuild public trust. This strategy integrates internal AI deployment and voluntary drug price negotiations to accelerate innovation while shifting federal cooperation with states toward data-driven surveillance and SNAP-funded nutrition improvements. Although government shutdowns have impacted staff morale, the administration targets a revitalized healthcare infrastructure through updated dietary guidelines and sustainable partnerships with industry and academia to combat chronic disease and pandemic risks.
- Milken Institute33 min
Conversation with FDA Commissioner Marty Makary & CMS Admin Mehmet Oz | Future of Health Summit 2025
Marty Makary, Mehmet Oz, Esther Krofah
The administration is driving a comprehensive healthcare overhaul that combines aggressive drug pricing strategies like "Most Favored Nation" with FDA reforms designed to slash biosimilar development times by reducing regulatory hurdles and replacing animal testing with computational models. Simultaneously, federal agencies are deploying $3 billion in savings from terminated contracts and AI tools to combat $100 billion in annual fraud while restructuring internal operations to accelerate clinical trial reviews and ensure domestic supply chain security. These initiatives aim to bridge the gap between the U.S.'s $4.9 trillion annual health expenditure and its lagging life expectancy by fostering data interoperability, enforcing new transparency rules, and launching the "Trump Rx" initiative to secure lower-cost, domestically produced medications for consumers.
- Milken Institute28 min
Centers for Medicare & Medicaid Services Administrator Mehmet Oz | Global Conference 2025
CMS Administrator Mehmet Oz has launched a strategic overhaul targeting an $80 billion annual savings by combating fraud, consolidating fragmented IT systems, and addressing lifestyle-driven chronic illness through the "Make America Healthy Again" initiative. The administration is restructuring federal incentives to support governors, deploying AI for real-time health notifications, and terminating wasteful contractors to fix systemic inefficiencies that currently cost the nation billions in duplicate payments and fraud. Oz warns that without these immediate structural interventions and a shift toward individual health responsibility, the Medicare and Medicaid system faces the risk of catastrophic collapse.
- Milken Institute21 min
A Conversation with Former First Lady of the United States Jill Biden | Global Conference 2025
At the 28th annual Milken Institute Global Conference, Dr. Jill Biden and Esther Kroffa outlined the Women's Health Network's strategy to address historical data gaps and the $1 trillion global economic opportunity by shifting funding reliance to the private sector. The initiative targets critical breakthroughs in areas like endometriosis diagnostics and Alzheimer's care while deploying a digital platform and pooled investment fund to dismantle data silos and accelerate inclusive innovation. By reframing women's health as a universal business imperative rather than a niche category, the network aims to impact millions of lives globally by 2025 through enhanced research inclusion and strategic capital allocation.
- Milken Institute31 min
Opening Remarks | Future of Health Summit 2024
The Milken Institute Future of Health Summit 2024 convenes over 200 global leaders across philanthropic, scientific, and governmental sectors to address critical health challenges like aging populations, rising chronic disease rates, and systemic access barriers. Featuring the theme "Partnering for Better Health," the event focuses on collaborative solutions to bridge the gap between massive healthcare investments and poor national outcomes, including a strategic shift from treatment to prevention. Discussions will examine how AI, biomedical innovation, and inclusive clinical trials can accelerate medical development while ensuring equitable access to care for diverse demographics.
- Milken Institute33 min
Global Health: Connectiveness for Better Outcomes | Asia Summit 2024
Esther Krofah, Mina Hamoodi, Ganen Sarvananthan, Tom Snow
Tom Snow's Snow Research Foundation, Lina Al Jaber's Mubadala, and Ganon Savaranthan's TPG Capital Asia outlined distinct strategies to accelerate healthcare innovation across the region through a combined focus on early-stage equity funding, sovereign wealth market expansion, and value-based service delivery. These leaders emphasized a shift from traditional grant models toward partnership-driven approaches that leverage local expertise to address Asia's unique demographic challenges, including rapid aging and the need for scalable clinical trials. By integrating advanced technologies like AI and electronic medical records with targeted investments in immunology, women's health, and infrastructure, the panelists aim to bridge the critical gap between academic discovery and commercial bedside application within one to two years.